In cardiac myocytes, Ca2+ is the second messenger of various physiological
processes, including the excitation-contraction coupling phenomenon. Here,
we examined how Ca2+ regulates cardiac myocyte apoptosis. Using an adult ra
t ventricular myocyte culture model, we found that ceramide (Cer) induces a
n apoptotic process that is highly sensitive to calcium: it is inhibited by
the Ca2+ buffer BAPTA-AM and is potentiated by the Ca2+ ionophore ionomyci
n. Cer-treated myocytes maintained their Ca2+ homeostasis and normal activi
ty of their voltage-dependent sarcolemmal Ca2+ entry pathways but showed en
hanced activity of B-type Ca2+ channels that were stimulated by Cer in the
inside-out patch clamp configuration. Pharmacological modulations of B-type
Ca2+ channels modulated Cer-induced apoptosis. Mitochondria were involved
in Cer-induced apoptosis, as indicated by the inhibitory effect of cyclospo
rine A and caspase-9 inhibitor. Both the loss of mitochondrial membrane pot
ential and the caspase-9 activation in Cer-treated myocytes were attenuated
by blocking B-type Ca2+ channels. The mitochondrial Ca2+ content was evalu
ated as changes in [Ca2+](i) after a short application of a mitochondrial u
ncoupler, FCCP, was increased in Cer-treated cells. Together, these results
show that Ca2+ modulates Cer-induced cardiac myocyte apoptosis through the
coupling of B-type Ca2+ channels with mitochondria.